A Pharmacogenomics Study of TAS-102 with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy
Latest Information Update: 03 Jan 2018
At a glance
- Drugs Tipiracil/trifluridine (Primary)
- Indications Colorectal cancer
- Focus Pharmacogenomic; Therapeutic Use
- Sponsors Taiho Pharmaceutical
- 11 Oct 2016 Results (n=179) presented at the 41st European Society for Medical Oncology Congress
- 09 Jun 2016 New trial record
- 13 Jan 2015 Status changed from active, no longer recruiting to completed.